K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that might lead to very serious consequences. Notably, mental status change, brain confusion, and smell and taste disorders along with neurological complaints have been reported in patients infecte...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/13/4142 |
_version_ | 1797408595438993408 |
---|---|
author | Simona Dedoni Valeria Avdoshina Chiara Camoglio Carlotta Siddi Walter Fratta Maria Scherma Paola Fadda |
author_facet | Simona Dedoni Valeria Avdoshina Chiara Camoglio Carlotta Siddi Walter Fratta Maria Scherma Paola Fadda |
author_sort | Simona Dedoni |
collection | DOAJ |
description | COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that might lead to very serious consequences. Notably, mental status change, brain confusion, and smell and taste disorders along with neurological complaints have been reported in patients infected with SARS-CoV-2. Furthermore, human brain tissue autopsies from COVID-19 patients show the presence of SARS-CoV-2 neuroinvasion, which correlates with the manifestation of meningitis, encephalitis, leukocyte infiltration, and neuronal damage. The olfactory mucosa has been suggested as a way of entry into the brain. SARS-CoV-2 infection is also known to provoke a hyper-inflammatory reaction with an exponential increase in the production of pro-inflammatory cytokines leading to systemic responses, even in the absence of direct infection of brain cells. Angiotensin-converting enzyme 2 (ACE2), the entry receptor of SARS-CoV-2, has been extensively demonstrated to be present in the periphery, neurons, and glial cells in different brain regions. To dissect the details of neurological complications and develop therapies helping COVID-19 survivors regain pre-infection quality of life, the development of robust clinical models is highly warranted. Several human angiotensin-converting enzyme 2 (hACE2) transgenic mouse models have been developed and used for antiviral drug screening and vaccine development, as well as for better understanding of the molecular pathogenetic mechanisms of SARS-CoV-2 infection. In this review, we summarize recent results from the studies involving two such mouse models, namely K18- and CAG-hACE2 transgenics, to evaluate the direct and indirect impact of SARS-CoV-2 infection on the central nervous system. |
first_indexed | 2024-03-09T04:01:44Z |
format | Article |
id | doaj.art-add7f108131149b08429059a4631e54e |
institution | Directory Open Access Journal |
issn | 1420-3049 |
language | English |
last_indexed | 2024-03-09T04:01:44Z |
publishDate | 2022-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Molecules |
spelling | doaj.art-add7f108131149b08429059a4631e54e2023-12-03T14:13:30ZengMDPI AGMolecules1420-30492022-06-012713414210.3390/molecules27134142K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration ResearchSimona Dedoni0Valeria Avdoshina1Chiara Camoglio2Carlotta Siddi3Walter Fratta4Maria Scherma5Paola Fadda6Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC 20057, USADepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyCOVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that might lead to very serious consequences. Notably, mental status change, brain confusion, and smell and taste disorders along with neurological complaints have been reported in patients infected with SARS-CoV-2. Furthermore, human brain tissue autopsies from COVID-19 patients show the presence of SARS-CoV-2 neuroinvasion, which correlates with the manifestation of meningitis, encephalitis, leukocyte infiltration, and neuronal damage. The olfactory mucosa has been suggested as a way of entry into the brain. SARS-CoV-2 infection is also known to provoke a hyper-inflammatory reaction with an exponential increase in the production of pro-inflammatory cytokines leading to systemic responses, even in the absence of direct infection of brain cells. Angiotensin-converting enzyme 2 (ACE2), the entry receptor of SARS-CoV-2, has been extensively demonstrated to be present in the periphery, neurons, and glial cells in different brain regions. To dissect the details of neurological complications and develop therapies helping COVID-19 survivors regain pre-infection quality of life, the development of robust clinical models is highly warranted. Several human angiotensin-converting enzyme 2 (hACE2) transgenic mouse models have been developed and used for antiviral drug screening and vaccine development, as well as for better understanding of the molecular pathogenetic mechanisms of SARS-CoV-2 infection. In this review, we summarize recent results from the studies involving two such mouse models, namely K18- and CAG-hACE2 transgenics, to evaluate the direct and indirect impact of SARS-CoV-2 infection on the central nervous system.https://www.mdpi.com/1420-3049/27/13/4142COVID-19K18-transgenic miceCAG-hACE2 transgenic miceneuroinvasioninflammation |
spellingShingle | Simona Dedoni Valeria Avdoshina Chiara Camoglio Carlotta Siddi Walter Fratta Maria Scherma Paola Fadda K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research Molecules COVID-19 K18-transgenic mice CAG-hACE2 transgenic mice neuroinvasion inflammation |
title | K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research |
title_full | K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research |
title_fullStr | K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research |
title_full_unstemmed | K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research |
title_short | K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research |
title_sort | k18 and cag hace2 transgenic mouse models and sars cov 2 implications for neurodegeneration research |
topic | COVID-19 K18-transgenic mice CAG-hACE2 transgenic mice neuroinvasion inflammation |
url | https://www.mdpi.com/1420-3049/27/13/4142 |
work_keys_str_mv | AT simonadedoni k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch AT valeriaavdoshina k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch AT chiaracamoglio k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch AT carlottasiddi k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch AT walterfratta k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch AT mariascherma k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch AT paolafadda k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch |